Jérémy Manry

1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
   2021/08/10 by Paul Bastard, Adrian Gervais, Tom Le Voyer +97 · 1 voice · 31 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #SARS-CoV-2 and COVID-19 Research #COVID-19 Clinical Research Studies #Diabetes and associated disorders
2. Autoantibodies against type I IFNs in patients with life-threatening COVID-19
   2020/09/24 by Paul Bastard, Lindsey B. Rosen, Qian Zhang +97 · 1 voice · 26 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #COVID-19 Clinical Research Studies #Diabetes and associated disorders #SARS-CoV-2 and COVID-19 Research
3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
   2020/09/24 by Qian Zhang, Paul Bastard, Zhiyong Liu +97 · 25 citations
   Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #Immunodeficiency and Autoimmune Disorders #Blood disorders and treatments #Diabetes and associated disorders
4. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
   2022/05/16 by Jérémy Manry, Paul Bastard, Adrian Gervais +97 · 1 voice · 5 citations
   Medicine · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #SARS-CoV-2 and COVID-19 Research